Serum Metabolomics in PCOS Women with Different Body Mass Index

Polycystic ovary syndrome (PCOS) is the most prevalent endocrine and metabolic disorder, affecting 5–10% of women of reproductive age. It results from complex environmental factors, genetic predisposition, hyperinsulinemia, hormonal imbalance, neuroendocrine abnormalities, chronic inflammation, and...

Full description

Bibliographic Details
Main Authors: Katarzyna Ożegowska, Szymon Plewa, Urszula Mantaj, Leszek Pawelczyk, Jan Matysiak
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/13/2811
id doaj-e0ec3c853e004b6aaba28bd43e4597e3
record_format Article
spelling doaj-e0ec3c853e004b6aaba28bd43e4597e32021-07-15T15:39:01ZengMDPI AGJournal of Clinical Medicine2077-03832021-06-01102811281110.3390/jcm10132811Serum Metabolomics in PCOS Women with Different Body Mass IndexKatarzyna Ożegowska0Szymon Plewa1Urszula Mantaj2Leszek Pawelczyk3Jan Matysiak4Department of Infertility and Reproductive Endocrinology, Poznan University of Medical Sciences, 61-701 Poznań, PolandDepartment of Inorganic and Analytical Chemistry, Poznan University of Medical Sciences, 61-701 Poznań, PolandDivision of Reproduction, Medical Faculty I, Poznan University of Medical Sciences, 61-701 Poznan, PolandDepartment of Infertility and Reproductive Endocrinology, Poznan University of Medical Sciences, 61-701 Poznań, PolandDepartment of Inorganic and Analytical Chemistry, Poznan University of Medical Sciences, 61-701 Poznań, PolandPolycystic ovary syndrome (PCOS) is the most prevalent endocrine and metabolic disorder, affecting 5–10% of women of reproductive age. It results from complex environmental factors, genetic predisposition, hyperinsulinemia, hormonal imbalance, neuroendocrine abnormalities, chronic inflammation, and autoimmune disorders. PCOS impacts menstrual regularities, fertility, and dermatological complications, and may induce metabolic disturbances, diabetes, and coronary heart disease. Comprehensive metabolic profiling of patients with PCOS may be a big step in understanding and treating the disease. The study aimed to search for potential differences in metabolites concentrations among women with PCOS according to different body mass index (BMI) in comparison to healthy controls. We used broad-spectrum targeted metabolomics to evaluate metabolites’ serum concentrations in PCOS patients and compared them with healthy controls. The measurements were performed using high-performance liquid chromatography coupled with the triple quadrupole tandem mass spectrometry technique, which has highly selective multiple reaction monitoring modes. The main differences were found in glycerophospholipid concentrations, with no specific tendency to up-or down-regulation. Insulin resistance and elevated body weight influence acylcarnitine C2 levels more than PCOS itself. Sphingomyelin (SM) C18:1 should be more intensively observed and examined in future studies and maybe serve as one of the PCOS biomarkers. No significant correlations were observed between anthropometric and hormonal parameters and metabolome results.https://www.mdpi.com/2077-0383/10/13/2811polycystic ovary syndromemetabolomemetabolic disturbancesbody mass indexinsulin resistancemetabolic pathways
collection DOAJ
language English
format Article
sources DOAJ
author Katarzyna Ożegowska
Szymon Plewa
Urszula Mantaj
Leszek Pawelczyk
Jan Matysiak
spellingShingle Katarzyna Ożegowska
Szymon Plewa
Urszula Mantaj
Leszek Pawelczyk
Jan Matysiak
Serum Metabolomics in PCOS Women with Different Body Mass Index
Journal of Clinical Medicine
polycystic ovary syndrome
metabolome
metabolic disturbances
body mass index
insulin resistance
metabolic pathways
author_facet Katarzyna Ożegowska
Szymon Plewa
Urszula Mantaj
Leszek Pawelczyk
Jan Matysiak
author_sort Katarzyna Ożegowska
title Serum Metabolomics in PCOS Women with Different Body Mass Index
title_short Serum Metabolomics in PCOS Women with Different Body Mass Index
title_full Serum Metabolomics in PCOS Women with Different Body Mass Index
title_fullStr Serum Metabolomics in PCOS Women with Different Body Mass Index
title_full_unstemmed Serum Metabolomics in PCOS Women with Different Body Mass Index
title_sort serum metabolomics in pcos women with different body mass index
publisher MDPI AG
series Journal of Clinical Medicine
issn 2077-0383
publishDate 2021-06-01
description Polycystic ovary syndrome (PCOS) is the most prevalent endocrine and metabolic disorder, affecting 5–10% of women of reproductive age. It results from complex environmental factors, genetic predisposition, hyperinsulinemia, hormonal imbalance, neuroendocrine abnormalities, chronic inflammation, and autoimmune disorders. PCOS impacts menstrual regularities, fertility, and dermatological complications, and may induce metabolic disturbances, diabetes, and coronary heart disease. Comprehensive metabolic profiling of patients with PCOS may be a big step in understanding and treating the disease. The study aimed to search for potential differences in metabolites concentrations among women with PCOS according to different body mass index (BMI) in comparison to healthy controls. We used broad-spectrum targeted metabolomics to evaluate metabolites’ serum concentrations in PCOS patients and compared them with healthy controls. The measurements were performed using high-performance liquid chromatography coupled with the triple quadrupole tandem mass spectrometry technique, which has highly selective multiple reaction monitoring modes. The main differences were found in glycerophospholipid concentrations, with no specific tendency to up-or down-regulation. Insulin resistance and elevated body weight influence acylcarnitine C2 levels more than PCOS itself. Sphingomyelin (SM) C18:1 should be more intensively observed and examined in future studies and maybe serve as one of the PCOS biomarkers. No significant correlations were observed between anthropometric and hormonal parameters and metabolome results.
topic polycystic ovary syndrome
metabolome
metabolic disturbances
body mass index
insulin resistance
metabolic pathways
url https://www.mdpi.com/2077-0383/10/13/2811
work_keys_str_mv AT katarzynaozegowska serummetabolomicsinpcoswomenwithdifferentbodymassindex
AT szymonplewa serummetabolomicsinpcoswomenwithdifferentbodymassindex
AT urszulamantaj serummetabolomicsinpcoswomenwithdifferentbodymassindex
AT leszekpawelczyk serummetabolomicsinpcoswomenwithdifferentbodymassindex
AT janmatysiak serummetabolomicsinpcoswomenwithdifferentbodymassindex
_version_ 1721299152518774784